Anke Krause

431 total citations
10 papers, 308 citations indexed

About

Anke Krause is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Anke Krause has authored 10 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Anke Krause's work include Ubiquitin and proteasome pathways (3 papers), Airway Management and Intubation Techniques (2 papers) and CAR-T cell therapy research (2 papers). Anke Krause is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Airway Management and Intubation Techniques (2 papers) and CAR-T cell therapy research (2 papers). Anke Krause collaborates with scholars based in Germany, Austria and United States. Anke Krause's co-authors include R. Jürgen Dohmen, Gerrit J. K. Praefcke, Kirstin Keusekotten, Christof Scheid, Sebastian Theurich, Michael Hallek, Udo Holtick, Alexander Shimabukuro‐Vornhagen, Geothy Chakupurakal and Michael von Bergwelt‐Baildon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical Journal.

In The Last Decade

Anke Krause

10 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anke Krause Germany 8 130 105 89 55 49 10 308
Blanca Molina Spain 11 44 0.3× 100 1.0× 178 2.0× 92 1.7× 56 1.1× 31 346
Carme Pedro Spain 12 59 0.5× 62 0.6× 185 2.1× 43 0.8× 27 0.6× 27 342
Te‐Kau Chang Taiwan 12 77 0.6× 24 0.2× 98 1.1× 29 0.5× 31 0.6× 26 298
PD Emanuel United States 5 68 0.5× 44 0.4× 221 2.5× 66 1.2× 17 0.3× 9 331
Francesca Vendemini Italy 10 136 1.0× 54 0.5× 121 1.4× 23 0.4× 42 0.9× 16 302
Stefanos I. Papadhimitriou Greece 10 39 0.3× 68 0.6× 126 1.4× 20 0.4× 91 1.9× 31 287
T Ninomiya Japan 9 46 0.4× 107 1.0× 213 2.4× 73 1.3× 48 1.0× 30 319
Lochie Teague New Zealand 12 49 0.4× 36 0.3× 169 1.9× 24 0.4× 97 2.0× 26 322
James E. Radford United States 6 30 0.2× 84 0.8× 90 1.0× 29 0.5× 67 1.4× 8 209
Lisa Wray United States 10 61 0.5× 271 2.6× 68 0.8× 69 1.3× 97 2.0× 22 398

Countries citing papers authored by Anke Krause

Since Specialization
Citations

This map shows the geographic impact of Anke Krause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Krause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Krause more than expected).

Fields of papers citing papers by Anke Krause

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Krause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Krause. The network helps show where Anke Krause may publish in the future.

Co-authorship network of co-authors of Anke Krause

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Krause. A scholar is included among the top collaborators of Anke Krause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Krause. Anke Krause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Holtick, Udo, Alexander Shimabukuro‐Vornhagen, Sebastian Theurich, et al.. (2015). OCTETCY: a phase II study to investigate the efficacy of post‐transplant cyclophosphamide as sole graft‐versus‐host prophylaxis after allogeneic peripheral blood stem cell transplantation. European Journal Of Haematology. 96(1). 27–35. 42 indexed citations
2.
Keusekotten, Kirstin, Katrin Fischer, Anke Krause, et al.. (2013). Multivalent interactions of the SUMO-interaction motifs in RING finger protein 4 determine the specificity for chains of the SUMO. Biochemical Journal. 457(1). 207–214. 33 indexed citations
3.
Uzunova, Kristina, et al.. (2012). Analysis of Cellular SUMO and SUMO–Ubiquitin Hybrid Conjugates. Methods in molecular biology. 832. 81–92. 2 indexed citations
5.
Spieth, Peter, Andreas Güldner, Alessandro Beda, et al.. (2012). Comparative effects of proportional assist and variable pressure support ventilation on lung function and damage in experimental lung injury*. Critical Care Medicine. 40(9). 2654–2661. 27 indexed citations
6.
Theurich, Sebastian, Kerstin Wennhold, Alexander Shimabukuro‐Vornhagen, et al.. (2012). Brentuximab Vedotin Combined With Donor Lymphocyte Infusions for Early Relapse of Hodgkin Lymphoma After Allogeneic Stem-Cell Transplantation Induces Tumor-Specific Immunity and Sustained Clinical Remission. Journal of Clinical Oncology. 31(5). e59–e63. 45 indexed citations
7.
8.
Keusekotten, Kirstin, et al.. (2008). Arsenic trioxide stimulates SUMO‐2/3 modification leading to RNF4‐dependent proteolytic targeting of PML. FEBS Letters. 582(21-22). 3174–3178. 91 indexed citations
9.
Krause, Anke, Martin R. Weihrauch, U. Bode, et al.. (2002). Carboxypeptidase-G 2 Rescue in Cancer Patients with Delayed Methotrexate Elimination after High-dose Methotrexate Therapy. Leukemia & lymphoma. 43(11). 2139–2143. 30 indexed citations
10.
Winkler, Tilo, et al.. (1995). Simulation of mechanical respiration using a multicompartment model for ventilation mechanics and gas exchange. International journal of clinical monitoring and computing. 12(4). 231–239. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026